Payment overview · 2025
General Payments
$8.92
1 reported records · 1 companies
Healthcare provider profile · identity verified
William A Willis, M.D.
Allopathic & Osteopathic Physicians|General Practice · POTEAU, OK · NPI 1205875846
Verified facts
What the public records show
CMS Open Payments records show William A Willis, M.D. received $8.92 in general payments during 2025 across 1 reported records.
Axsome Therapeutics, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Axsome Therapeutics, Inc. | Unresolved — no canonical attribution shown | $8.92 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $8.92 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Auvelity Normalized: auvelity |
Drug | Axsome Therapeutics, Inc. | $8.92 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 1545 | 314 |
| Oxycodone Hcl | Oxycodone Hcl | 627 | 100 |
| Zolpidem Tartrate | Zolpidem Tartrate | 428 | 68 |
| Gabapentin | Gabapentin | 414 | 62 |
| Lisinopril | Lisinopril | 244 | 61 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 215 | 40 |
| Omeprazole | Omeprazole | 207 | 48 |
| Levothyroxine Sodium | Levothyroxine Sodium | 188 | 46 |
| Alprazolam | Alprazolam | 169 | 19 |
| Tamsulosin Hcl | Tamsulosin Hcl | 169 | 32 |
| Atorvastatin Calcium | Atorvastatin Calcium | 166 | 56 |
| Potassium Chloride | Potassium Chloride | 166 | 48 |
| Metoprolol Tartrate | Metoprolol Tartrate | 164 | 31 |
| Furosemide | Furosemide | 163 | 39 |
| Losartan Potassium | Losartan Potassium | 150 | 36 |
| Clonidine Hcl | Clonidine Hcl | 141 | 33 |
| Amlodipine Besylate | Amlodipine Besylate | 140 | 34 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 122 | 58 |
| Pantoprazole Sodium | Pantoprazole Sodium | 117 | 32 |
| Clopidogrel | Clopidogrel Bisulfate | 112 | 25 |
| Duloxetine Hcl | Duloxetine Hcl | 108 | 22 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 101 | 14 |
| Hydrochlorothiazide | Hydrochlorothiazide | 99 | 22 |
| Ondansetron Odt | Ondansetron | 94 | 30 |
| Metformin Hcl | Metformin Hcl | 92 | 22 |
| Pregabalin | Pregabalin | 90 | 37 |
| Baclofen | Baclofen | 85 | 24 |
| Carvedilol | Carvedilol | 80 | 16 |
| Montelukast Sodium | Montelukast Sodium | 77 | 13 |
| Lorazepam | Lorazepam | 74 | 11 |
| Metoprolol Succinate | Metoprolol Succinate | 71 | 17 |
| Sertraline Hcl | Sertraline Hcl | 71 | 18 |
| Meloxicam | Meloxicam | 67 | 18 |
| Tramadol Hcl | Tramadol Hcl | 67 | 28 |
| Fluticasone Propionate | Fluticasone Propionate | 61 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 59 | 42 |
| Atenolol | Atenolol | 57 | 11 |
| Pravastatin Sodium | Pravastatin Sodium | 55 | 17 |
| Allopurinol | Allopurinol | 54 | 11 |
| Eliquis | Apixaban | 54 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 54 | 16 |
| Morphine Sulfate Er | Morphine Sulfate | 52 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 52 | 15 |
| Eszopiclone | Eszopiclone | 51 | 14 |
| Mirtazapine | Mirtazapine | 49 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 48 | suppressed |
| Ozempic | Semaglutide | 46 | 12 |
| Quetiapine Fumarate | Quetiapine Fumarate | 45 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 44 | 11 |
| Azithromycin | Azithromycin | 43 | 30 |
| Amoxicillin | Amoxicillin | 41 | 34 |
| Trazodone Hcl | Trazodone Hcl | 41 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 39 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 38 | 28 |
| Bupropion Xl | Bupropion Hcl | 37 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 37 | suppressed |
| Ranolazine Er | Ranolazine | 37 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 36 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 35 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 34 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 33 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 31 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 31 | suppressed |
| Ibuprofen | Ibuprofen | 31 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 30 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 30 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 30 | suppressed |
| Synthroid | Levothyroxine Sodium | 30 | suppressed |
| Estradiol | Estradiol | 29 | suppressed |
| Glipizide | Glipizide | 29 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 29 | suppressed |
| Sucralfate | Sucralfate | 29 | 12 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 27 | 24 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 27 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 26 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 26 | suppressed |
| Nitroglycerin | Nitroglycerin | 26 | 14 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 25 | suppressed |
| Lovastatin | Lovastatin | 25 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 25 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 24 | suppressed |
| Fluconazole | Fluconazole | 24 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 24 | suppressed |
| Bumetanide | Bumetanide | 22 | suppressed |
| Temazepam | Temazepam | 22 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 21 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 20 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 20 | suppressed |
| Simvastatin | Simvastatin | 20 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 20 | suppressed |
| Celecoxib | Celecoxib | 19 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 19 | suppressed |
| Nifedipine Er | Nifedipine | 19 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 18 | suppressed |
| Methylprednisolone | Methylprednisolone | 18 | 14 |
| Ondansetron Hcl | Ondansetron Hcl | 18 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 18 | 15 |
| Topiramate | Topiramate | 18 | suppressed |
| Clonazepam | Clonazepam | 17 | suppressed |
| Glipizide Er | Glipizide | 17 | suppressed |
| Movantik | Naloxegol Oxalate | 17 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 17 | suppressed |
| Acyclovir | Acyclovir | 16 | suppressed |
| Cephalexin | Cephalexin | 16 | 12 |
| Metformin Hcl Er | Metformin Hcl | 16 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 16 | suppressed |
| Glimepiride | Glimepiride | 15 | suppressed |
| Mupirocin | Mupirocin | 15 | suppressed |
| Buprenorphine | Buprenorphine | 14 | suppressed |
| Fetzima | Levomilnacipran Hcl | 14 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 14 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 14 | suppressed |
| Valsartan | Valsartan | 14 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 13 | suppressed |
| Diazepam | Diazepam | 13 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 13 | suppressed |
| Calcitriol | Calcitriol | 12 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 12 | suppressed |
| Ezetimibe | Ezetimibe | 12 | suppressed |
| Famotidine | Famotidine | 12 | suppressed |
| Fenofibrate | Fenofibrate | 12 | suppressed |
| Finasteride | Finasteride | 12 | suppressed |
| Gemtesa | Vibegron | 12 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 12 | suppressed |
| Linzess | Linaclotide | 12 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 12 | suppressed |
| Methadone Hcl | Methadone Hcl | 12 | suppressed |
| Methylphenidate Er | Methylphenidate Hcl | 12 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 11 | suppressed |
| Myrbetriq | Mirabegron | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $8.92 · 1 records | Axsome Therapeutics, Inc. | Auvelity | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error